5-(n,n-hexamethylene)amiloride has been researched along with gamma-aminobutyric acid in 2 studies
*gamma-Aminobutyric Acid: The most common inhibitory neurotransmitter in the central nervous system. [MeSH]
*gamma-Aminobutyric Acid: The most common inhibitory neurotransmitter in the central nervous system. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Gonzales, EB; Snell, HD | 1 |
2 other study(ies) available for 5-(n,n-hexamethylene)amiloride and gamma-aminobutyric acid
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
5-(N, N-Hexamethylene) amiloride is a GABA-A ρ1 receptor positive allosteric modulator.
Topics: Allosteric Regulation; Amiloride; Binding Sites; Electrophysiology; gamma-Aminobutyric Acid; Guanidine; HEK293 Cells; Humans; Mutagenesis, Site-Directed; Receptors, GABA-B | 2016 |